Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells | Zendy

AI Assistant Blog Pricing

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.